The store will not work correctly when cookies are disabled.
5-(3,4-Dihydroxy-pyrrolidin-2-yl)-2-methyl-furan-3-carboxylic acid diethylamide
ID: ALA2114149
PubChem CID: 513283
Max Phase: Preclinical
Molecular Formula: C14H22N2O4
Molecular Weight: 282.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCN(CC)C(=O)c1cc([C@H]2NC[C@@H](O)[C@H]2O)oc1C
Standard InChI: InChI=1S/C14H22N2O4/c1-4-16(5-2)14(19)9-6-11(20-8(9)3)12-13(18)10(17)7-15-12/h6,10,12-13,15,17-18H,4-5,7H2,1-3H3/t10-,12-,13-/m1/s1
Standard InChI Key: JMGMYORMUHCVGM-RAIGVLPGSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
2.9321 -1.4640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0005 -2.4206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1211 -1.6013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2851 -2.8323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3064 -0.7237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3106 -2.1835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7450 -2.7824 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.5240 -2.5329 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2394 -3.6558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4492 -3.8679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1299 -0.6780 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -3.1692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8573 -0.0291 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8758 -4.1715 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.1414 -4.6415 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1341 -2.2833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5791 -1.3725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4960 0.0582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4026 -1.3226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3194 0.0998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 1 1 0
4 2 1 6
5 1 1 0
6 1 2 0
7 6 1 0
8 4 1 0
9 4 1 0
10 9 1 0
11 5 1 0
12 8 1 0
13 5 2 0
9 14 1 6
10 15 1 6
16 6 1 0
17 11 1 0
18 11 1 0
19 17 1 0
20 18 1 0
2 7 1 0
10 12 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 282.34 | Molecular Weight (Monoisotopic): 282.1580 | AlogP: 0.44 | #Rotatable Bonds: 4 |
Polar Surface Area: 85.94 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.17 | CX Basic pKa: 7.68 | CX LogP: -0.57 | CX LogD: -1.03 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.75 | Np Likeness Score: -0.17 |
References
1. Moreno-Vargas AJ, Demange R, Fuentes J, Robina I, Vogel P.. (2002) Synthesis of [(2S,3S,4R)-3,4-dihydroxypyrrolidin-2-yl]-5-methylfuran-4-carboxylic acid derivatives: new leads as selective beta-galactosidase inhibitors., 12 (17): [PMID:12161128] [10.1016/s0960-894x(02)00397-9] |